Epkinly

Active Ingredient(s): Epcoritamab-bysp
FDA Approved: * May 19, 2023
Pharm Company: * GENMAB US, INC.
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Epkinly 4 mg/.8ml Subcutaneous Injection, Solution, Concentrate
NDC: 82705-002
Labeler:
Genmab Us, Inc.
Epkinly 48 mg/.8ml Subcutaneous Injection, Solution
NDC: 82705-010
Labeler:
Genmab Us, Inc.